Managing Malignant Pleural Mesothelioma in the Age of Personalized Medicine: Where Are We and What Is Still Missing?

Giulia Maria Stella; Chandra Bortolotto

doi:10.3390/cancers14225540

Managing Malignant Pleural Mesothelioma in the Age of Personalized Medicine: Where Are We and What Is Still Missing?

Cancers (Basel). 2022 Nov 11;14(22):5540. doi: 10.3390/cancers14225540.

Authors

Giulia Maria Stella^{1

2}, Chandra Bortolotto^{3

4}

Affiliations

¹ Department of Internal Medicine and Medical Therapeutics, University of Pavia Medical School, 27100 Pavia, Italy.
² Cardio-Thoraco-Vascular Department, Unit of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation and University of Pavia Medical School, 27100 Pavia, Italy.
³ Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.
⁴ Department of Diagnostic and Imaging Services, Unit of Radiology, and University of Pavia Medical School, 27100 Pavia, Italy.

Abstract

Malignant Mesothelioma (MM) is an aggressive neoplasm of the pleural mesothelium, less frequently peritoneal and exceptionally of the vaginal tunic of the testicle and pericardium [...].

Publication types

Editorial